Departments of Pathology, Democritus University of Thrace Medical School, Alexandroupolis, Greece.
Radiotherapy/Oncology, Democritus University of Thrace Medical School, Alexandroupolis, Greece.
Chest. 2011 Jul;140(1):127-134. doi: 10.1378/chest.10-1831. Epub 2010 Dec 9.
Lung carcinoma has a poor prognosis that is mainly predicted by the stage of the disease. Despite evaluation of various prognostic factors, the role of autophagy, a self-degradative process involved in the turnover of cytoplasmic material, remains unexplored in lung malignancy.
Autophagic activity was investigated in 115 patients with non-small cell lung carcinoma treated with surgery (64 squamous cell carcinomas, 24 adenocarcinomas of mixed subtype, 18 large cell carcinomas, 9 uncommon types). The median overall survival was 32 months (range, 2-102 months). We used the MAP1LC3A antibody and a standard immunohistochemical technique. Autophagic activity was correlated with clinical and pathologic parameters.
Immunohistochemical examination revealed three patterns of autophagic activity: diffuse cytoplasmic, cytoplasmic perinuclear, and "stone-like" structures (SLSs), which are dense, rounded cytosolic structures typically enclosed within light-chain 3 (LC3) A-positive vacuoles. A high SLS count was associated with a reduction of the overall median survival from 88 to 15 months and constituted the strongest independent variable in multivariate analysis. Interestingly, a high presence of SLS defined significantly poor prognosis within stage I and II, whereas a similar trend was noted within stage III. The other two patterns of LC3A reactivity were not correlated with prognosis.
Exaggerated autophagy, as indicated by the intense presence of SLSs, is strongly correlated with a poor outcome in non-small cell lung carcinoma, suggesting possibly that autophagy functions as a survival tool in cancer cells.
肺癌的预后较差,主要由疾病分期预测。尽管评估了各种预后因素,但自噬(一种涉及细胞质物质更新的自我降解过程)在肺癌中的作用仍未得到探索。
对 115 例接受手术治疗的非小细胞肺癌患者(64 例鳞状细胞癌、24 例混合亚型腺癌、18 例大细胞癌、9 例罕见类型)进行自噬活性研究。中位总生存期为 32 个月(范围为 2-102 个月)。我们使用 MAP1LC3A 抗体和标准免疫组织化学技术。自噬活性与临床和病理参数相关。
免疫组织化学检查显示三种自噬活性模式:弥漫性细胞质、细胞质核周和“石样”结构(SLS),其为典型被 LC3A 阳性空泡包裹的密集、圆形细胞质结构。高 SLS 计数与总生存期从 88 个月缩短至 15 个月相关,并且是多变量分析中最强的独立变量。有趣的是,高 SLS 存在显著定义了 I 期和 II 期的不良预后,而在 III 期也存在类似趋势。LC3A 反应的另外两种模式与预后无关。
强烈存在 SLS 表明自噬过度,与非小细胞肺癌不良预后强烈相关,提示自噬可能作为癌细胞的生存工具发挥作用。